Poorly Differentiated Neuroendocrine Tumor With 18F-Fluciclovine Uptake in a Patient With Metastatic Castrate-Resistant Prostate Cancer

被引：2
|
作者：
Abiodun-Ojo, Olayinka A. [1 ]
Akintayo, Akinyemi A. [1 ]
Harik, Lara R. [2 ]
Bilen, Mehmet [3 ]
Halkar, Raghuveer K. [1 ]
机构：
[1] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA USA
[2] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[3] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2021年 / 46卷 / 05期
关键词：
F-18-fluciclovine; axumin; F-18-FDG; neuroendocrine tumor; prostate cancer; PET; FDG-PET; UTILITY;
D O I：
10.1097/RLU.0000000000003408
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
F-18-Fluciclovine is an amino acid-based radiopharmaceutical used primarily for PET imaging of patients with biochemical recurrence of prostate cancer. We report a case of a 66-year-old man with recently diagnosed metastatic castrate-resistant prostate cancer and a left supraclavicular lymph node with incidental radiotracer uptake on F-18-fluciclovine PET/CT. Left neck core needle biopsy confirmed high-grade, poorly differentiated carcinoma with neuroendocrine features positive for synaptophysin and chromogranin, and negative for prostate markers.
引用
收藏
页码：E282 / E285
页数：4
相关论文
共 50 条
  • [1] Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer
    Chu, Carissa
    Alshalalfa, Mohammed
    Sjostrom, Martin
    Zhao, Shuang
    Herlemann, Annika
    Chou, Jonathan
    Baskin, Avi Lefridge
    Mahal, Brandon Arvin Virgil
    Spratt, Daniel Eidelberg
    Cooperberg, Matthew R.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    Wong, Anthony C.
    Porten, Sima P.
    Hope, Thomas
    Nguyen, Paul L.
    Schaeffer, Edward M.
    Carroll, Peter
    Feng, Felix Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [2] Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence
    Nguyen, Nghi C.
    Muthukrishnan, Ashok
    Mountz, James M.
    [J]. CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : E63 - E64
  • [3] 18F-Fluciclovine Uptake in an Incidentally Discovered Meningioma in a Patient With a History of Metastatic Prostate Cancer: A Case Report
    Touma, Danielle A.
    Hayes, Horace
    Cloran, Francis J.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [4] Metastatic castrate-resistant prostate cancer
    Schellhammer, Paul
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 51 - 52
  • [5] Extraprostatic Uptake of 18F-Fluciclovine: Differentiation of Nonprostatic Neoplasms From Metastatic Prostate Cancer
    Robertson, Matthew S.
    Sakellis, Christopher G.
    Hyun, Hyewon
    Jacene, Heather A.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 214 (03) : 641 - 648
  • [6] Prostate Cancer Imaging with 18F-Fluciclovine
    Savir-Baruch, Bital
    Schuster, David M.
    [J]. PET CLINICS, 2022, 17 (04) : 607 - 620
  • [7] Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer
    Baiomy, Ali
    Jensen, Corey T.
    Ward, John F.
    Chasen, Beth A.
    Ravizzini, Gregory C.
    [J]. CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : 355 - 357
  • [8] Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Karnes, R. Jeffrey
    Ahmed, Mohamed E.
    [J]. APPLIED RADIOLOGY, 2021, 50 (01) : 42 - 43
  • [9] Olaparib in metastatic castrate-resistant prostate cancer
    不详
    [J]. BJU INTERNATIONAL, 2020, 126 (02) : 235 - 235
  • [10] 18F-Fluciclovine PET in Recurrent Prostate Cancer
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (04) : 17N - 17N
12345